FILL/FINISH OUTSOURCED PHARMA CAPACITY UPDATE VIDEOS
FUJIFILM Diosynth Biotechnologies Capacity Update July 2024: Fill/Finish
Nadiyra Walker, Head of Drug Product and Finished Goods Manufacturing at FUJIFILM Diosynth Biotechnologies (FDB), presents an update on the state of FDB’s Drug Product and Finished Goods capabilities.
Ajinomoto Bio-Pharma Services Capacity Update July 2024: Fill/Finish
Review our range of offerings including our high speed, multi-purpose fill finish line for vials, syringes, and cartridges located in our manufacturing facilities in San Diego, CA.
Singota Solutions Capacity Update July 2024: Fill/Finish
Review key services including drug formulation development, analytical testing, aseptic filling, pharmaceutical labeling and kitting, and supply chain management.
Mabion Capacity Update July 2024: Fill/Finish
Mabion, a biologics CDMO with end-to-end services focusing on recombinant proteins development and production, showcases new depyrogenation, fill finish vial capabilities, and CMC analytical proficiencies.
Simtra BioPharma Solutions Capacity Update July 2024: Fill/Finish
We currently have open capacity for development services as well as liquid vial projects at both manufacturing sites and can support rapid tech transfer depending on the complexity of the project.
Mycenax Capacity Update July 2024: Fill/Finish
Our capabilities include filling vials (liquid or lyophilized), pre-filled syringes (PFS), and cartridge product types, supporting batch sizes of 1,000 to 100,000 vials and up to 120 batches annually.
AbbVie Capacity Update May 2024: Fill/Finish
We leverage decades of scientific expertise, operational excellence, and state-of-the-art facilities to provide one of the most reliable manufacturing options for fill-finish processes.
IDT Biologika Capacity Update May 2024: Fill/Finish
We are a sustainable partner in the commercial manufacturing of your liquid products. To advance the therapeutic and prophylactic therapies of clients, we have set up new state-of-the-art high-speed filling capacities.
PCI Pharma Services Capacity Update May 2024: Fill/Finish
Review our global sterile fill-finish and lyophilization capabilities, capacities, and how strategic investments allow us to meet the growing need for expert sterile development and manufacturing.
Pfizer CentreOne Capacity Update May 2024: Fill/Finish
Review Pfizer CentreOne’s overall sterile injectable drug substance capabilities, with a focus on our ability to help meet your complex sterile injectable needs.
Novartis Contract Manufacturing Capacity Update May 2024: Fill/Finish
Learn more about our integrated offerings in mammalian drug substance and drug product. Our drug product (Fill & Finish) services cover vials (LivI, Lyo), syringes (PFS), Cartrdiges and Auto Injectors.
Resilience Capacity Update May 2024: Fill/Finish
Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. Hear about how we can support manufacturing programs from clinical through commercial.
Alcami Capacity Update May 2024: Fill/Finish
Alcami offers sterile drug product fill finish services including formulation development, complex formulations, clinical manufacturing, batch scale-up, and commercial manufacturing.
Ajinomoto Bio-Pharma Services Capacity Update May 2024: Fill/Finish
Explore our range of offerings, including our high-speed, multi-purpose fill finish line for vials, syringes, and cartridges located in our manufacturing facilities in San Diego, CA.
Capacity Update May 2024: Fill/Finish
INCOG has been designed and built to deliver better CDMO services in the injectable drug product space. Gain an overview and update of our expanding capabilities as we provide you with an inside look at our facility.
Don't miss our next installment!
These conferences are ideal for professionals who have the authority to choose and manage CDMO relationships and need to secure capacity for their development or commercial programs.
How can we help?
Are you a supplier looking to present at our next event?